EMvision Director’s 300,000 Options Lapse at Expiry Without Exercise

The latest announcement is out from EMvision Medical Devices Ltd. ( (AU:EMV) ).

EMvision Medical Devices Ltd has disclosed a change in director John Keep’s interests following the expiry and lapse of 300,000 unlisted options exercisable at $2.25 that were held through Glensburg Pty Ltd as trustee for the Tyto Corporation Pension Fund. The options expired on 31 December 2025 without being exercised, leaving Keep’s overall equity exposure unchanged in terms of ordinary shares, which remain at a combined 2,066,670 EMV shares held directly and via associated entities; the lapse removes a potential future source of share dilution and slightly reduces the director’s leveraged upside exposure to the company’s share price.

The most recent analyst rating on (AU:EMV) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on EMvision Medical Devices Ltd. stock, see the AU:EMV Stock Forecast page.

More about EMvision Medical Devices Ltd.

EMvision Medical Devices Ltd is an Australian-listed medical technology company developing medical devices, with its securities traded on the ASX under the code EMV. The company’s register includes substantial shareholdings and options held by directors and associated entities, reflecting typical equity-based alignment of management with shareholder interests.

Average Trading Volume: 56,535

Technical Sentiment Signal: Sell

Current Market Cap: A$165.4M

Learn more about EMV stock on TipRanks’ Stock Analysis page.